ABL (ABL, Inc. / ABL Europe)
Is this your company? Claim this profile
Drug Product
Advanced Modalities
Company Overview
About
ABL (ABL, Inc. / ABL Europe) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:France
Founded:2004
Employees:1,255
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval EG5VV0
EMA · #APR-0L2WU7JM · 2020-10-01
Drug Approval W1P6JW
Health Canada · #APR-FR3W8AKZ · 2019-04-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-DLNLMLUB
Issued: 2020-09-02
Expires: 2025-06-12
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-R7P3ZD2Y
Issued: 2020-10-14
Expires: 2025-12-16
Loading CDMO intelligence...
Key facts about ABL (ABL, Inc. / ABL Europe)
- ABL (ABL, Inc. / ABL Europe) is headquartered in France.
- ABL (ABL, Inc. / ABL Europe) was founded in 2004.
- ABL (ABL, Inc. / ABL Europe) has 1,255 employees.
- ABL (ABL, Inc. / ABL Europe)'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like ABL (ABL, Inc. / ABL Europe)
Directory pages this company appears in, each with the full list of matching manufacturers.